STING1 and cancer: ,70 Of interest, increased cGAS-STING signaling is beneficial in certain pathologies, such as cancer, where AIM2 depletion promotes anti-tumor responses by enhancing STING-dependent type I IFN responses,9 suggesting specific AIM2 inhibitors are useful but require careful consideration.